These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18273406)
1. Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus. Dover SE; Aroutcheva AA; Faro S; Chikindas ML Infect Dis Obstet Gynecol; 2007; 2007():78248. PubMed ID: 18273406 [TBL] [Abstract][Full Text] [Related]
2. Mode of action of lactocin 160, a bacteriocin from vaginal Lactobacillus rhamnosus. Li J; Aroutcheva AA; Faro S; Chikindas ML Infect Dis Obstet Gynecol; 2005 Sep; 13(3):135-40. PubMed ID: 16126497 [TBL] [Abstract][Full Text] [Related]
3. Development of an in vitro alternative assay method for vaginal irritation. Ayehunie S; Cannon C; Larosa K; Pudney J; Anderson DJ; Klausner M Toxicology; 2011 Jan; 279(1-3):130-8. PubMed ID: 20937349 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of safety margins of Chenopodium album seed decoction: 14-day subacute toxicity and microbicidal activity studies. Kumar S; Biswas S; Banerjee S; Mondal NB Reprod Biol Endocrinol; 2011 Jul; 9():102. PubMed ID: 21801392 [TBL] [Abstract][Full Text] [Related]
6. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis. Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations. Verdenelli MC; Coman MM; Cecchini C; Silvi S; Orpianesi C; Cresci A J Appl Microbiol; 2014 May; 116(5):1297-307. PubMed ID: 24552173 [TBL] [Abstract][Full Text] [Related]
8. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis. Pino A; Rapisarda AMC; Vitale SG; Cianci S; Caggia C; Randazzo CL; Cianci A Sci Rep; 2021 Jan; 11(1):2592. PubMed ID: 33510271 [TBL] [Abstract][Full Text] [Related]
9. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768 [TBL] [Abstract][Full Text] [Related]
10. Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina. Pascual LM; Daniele MB; Ruiz F; Giordano W; Pájaro C; Barberis L J Gen Appl Microbiol; 2008 Jun; 54(3):141-8. PubMed ID: 18654035 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of antimicrobial activity of Lactobacillus rhamnosus IMC 501(®) , Lactobacillus paracasei IMC 502(®) and SYNBIO(®) against pathogens. Coman MM; Verdenelli MC; Cecchini C; Silvi S; Orpianesi C; Boyko N; Cresci A J Appl Microbiol; 2014 Aug; 117(2):518-27. PubMed ID: 24836638 [TBL] [Abstract][Full Text] [Related]
13. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein. D'Cruz OJ; Waurzyniak B; Uckun FM Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159 [TBL] [Abstract][Full Text] [Related]
14. Normal vaginal flora, disorders and application of probiotics in pregnancy. Stojanović N; Plećaš D; Plešinac S Arch Gynecol Obstet; 2012 Aug; 286(2):325-32. PubMed ID: 22437191 [TBL] [Abstract][Full Text] [Related]
15. Assessment of exopolysaccharides, bacteriocins and in vitro and in vivo hypocholesterolemic potential of some Egyptian Lactobacillus spp. El-Dein AN; Nour El-Deen AM; El-Shatoury EH; Awad GA; Ibrahim MK; Awad HM; Farid MA Int J Biol Macromol; 2021 Mar; 173():66-78. PubMed ID: 33482208 [TBL] [Abstract][Full Text] [Related]
16. Probiotics for the treatment of women with bacterial vaginosis. Falagas M; Betsi GI; Athanasiou S Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390 [TBL] [Abstract][Full Text] [Related]
17. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433 [TBL] [Abstract][Full Text] [Related]
18. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial]. Kovachev S; Dobrevski-Vacheva R Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744 [TBL] [Abstract][Full Text] [Related]